Beech Tree Labs, Inc., announced today that the FDA has approved its IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza virus infections.
The Eppendorf Award for Young European Investigators (established in 1995) acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts. The Eppendorf Award is presented in partnership with Nature.
For more than 15 years, Eppendorf BioNews biannual magazine has been a popular source of information for researchers worldwide. The leading article focuses on the Eppendorf Research® plus pipette family. This new generation of ultra light single channel and multi channel pipettes meets the highest demands in precision and accuracy, combined with perfect ergonomics and increased flexibility.
"Simply better pipetting" - Eppendorf presents its new electronic pipette Eppendorf Xplorer® at the Analytica 2010. The intuitive operating concept and ergonomic display set new standards in simplicity, precision and reproducibility.
Eppendorf AG and the world-renowned journal Science are now accepting applications for the 2010 Eppendorf and Science Prize for Neurobiology.
Eurand, a global specialty pharmaceutical company, has announced data from a Phase II/III clinical study demonstrating that ZENPEP (pancrelipase) delayed-release capsules significantly improves fat absorption in patients with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis.
Cancer Research Technology (CRT) announced today an exclusive agreement with Cephalon, Inc., an international biotechnology company, to collaborate on the development of small molecule inhibitors. These molecules will target specific members of the Protein Kinase C superfamily of cell signalling proteins - which have been shown to be associated with the development of cancer.
NSF International recently announced the acquisition of David Begg Associates (DBA), a UK-based organisation that provides professional, high-quality training and auditing solutions to the pharmaceutical and healthcare industries.
The Custom Pharmaceutical Services (CPS) business of Dr. Reddy's Laboratories Ltd. today announced the successful commissioning of its commercial scale manufacturing facility for pharma grade mPEG alcohols at its Cuernavaca facility in Mexico.
Dr. Reddy's has announced the appointment of Sanjeev Verma as the new head for corporate communications and branding.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.